Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients
Myasthenia gravis (MG) is a chronic autoimmune disorder characterized by muscle weakness and caused by pathogenic autoantibodies that bind to membrane proteins at the neuromuscular junction. Most patients have autoantibodies against the acetylcholine receptor (AChR), but a subset of patients have au...
Asıl Yazarlar: | Takata, K, Stathopoulos, P, Cao, M, Mané-Damas, M, Fichtner, M, Benotti, E, Jacobson, L, Waters, P, Irani, S, Martinez-Martinez, P, Beeson, D, Losen, M, Vincent, A, Nowak, R, O'Connor, K |
---|---|
Materyal Türü: | Journal article |
Baskı/Yayın Bilgisi: |
American Society for Clinical Investigation
2019
|
Benzer Materyaller
-
Diagnostic use of autoantibodies in myasthenia gravis.
Yazar:: Leite, M, ve diğerleri
Baskı/Yayın Bilgisi: (2010) -
Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy
Yazar:: Miriam L. Fichtner, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01) -
Silencing of Dok-7 in adult rat muscle increases susceptibility to passive transfer myasthenia gravis
Yazar:: Gomez, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016) -
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.
Yazar:: Miriam L Fichtner, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01) -
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity
Yazar:: Miriam L. Fichtner, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)